FluGen
Madison, US · Wisconsin corporation · 2 known investors
Biotech
Founders & leadership
DS
Dan StinchcombDirector
CB
C. Boyd ClarkeDirector
PM
Phillip M. HalpernDirector
PV
Paul V. RadspinnerExecutive Officer, Director
DG
David G. WalshDirector
PB
Pamuk BilselExecutive Officer
PW
Paul WeissDirector
CH
Craig HeimDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$8.2MraisedMay 2020 · 47 investors · BiotechnologyRule 506(b)
▶$8.2MraisedMay 2020 · 47 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul WeissDirector
- Eric PatzerDirector
- David G. WalshDirector
- Paul V. RadspinnerExecutive Officer, Director
- Erik IversonDirector
- C. Boyd ClarkeDirector
- David NewbergDirector
- Pamuk BilselExecutive Officer
- Offering amount
- $8.5M
- Amount sold
- $8.2M
- First sale
- Apr 2020
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
▶$5.6MraisedNov 2018 · 36 investors · BiotechnologyRule 506(b)
▶$5.6MraisedNov 2018 · 36 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Pamuk BilselExecutive Officer
- C. Boyd ClarkeDirector
- Michael WagnerDirector
- Paul WeissDirector
- Phillip M. HalpernDirector
- Paul V. RadspinnerExecutive Officer, Director
- David G. WalshDirector
- Offering amount
- $5.6M
- Amount sold
- $5.6M
- First sale
- Oct 2018
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
▶$5.5MraisedAug 2017 · 25 investors · BiotechnologyRule 506(b)
▶$5.5MraisedAug 2017 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael WagnerDirector
- David G. WalshDirector
- Phillip M. HalpernDirector
- Paul V. RadspinnerExecutive Officer, Director
- Dan StinchcombDirector
- Pamuk BilselExecutive Officer
- Paul WeissDirector
- C. Boyd ClarkeDirector
- Offering amount
- $5.5M
- Amount sold
- $5.5M
- First sale
- Jun 2017
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
▶$11.4MraisedApr 2017 · 29 investors · BiotechnologyRule 506(b)
▶$11.4MraisedApr 2017 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dan StinchcombDirector
- C. Boyd ClarkeDirector
- Phillip M. HalpernDirector
- Paul V. RadspinnerExecutive Officer, Director
- David G. WalshDirector
- Pamuk BilselExecutive Officer
- Paul WeissDirector
- Craig HeimDirector
- Offering amount
- $11.4M
- Amount sold
- $11.4M
- First sale
- Aug 2015
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.